BARDA Industry Day 2023 (Hybrid Event)
The COVID-19 pandemic has highlighted the need for new and innovative medical countermeasures (MCMs) to prepare for and respond to public health emergencies in our ever-changing and unpredictable world. While BARDA has successfully established an ecosystem of innovation through programs like CARB-X, BARDA Ventures, the Accelerator Network, and the Blue Knight program, the organization continues to work through public-private partnerships to innovate and advance MCMs that protect against health security threats. Project NextGen is the latest example of BARDA fortifying the nation’s health security by working closely with our partner companies to bring medical countermeasures from the laboratory bench to the patient’s bedside.
BARDA Industry Day (BID) is our annual opportunity to foster new collaborations, share goals, objectives, and opportunities for partnership, and discuss opportunities for partnership and funding for companies interested in working with the U.S. government to achieve our MCM priorities. This event is not only educational, but also facilitates collaboration between public and private sectors within the health security space. Read more to see additional details on this year’s event.
BID 2023 will be a hybrid event, taking place both virtually and held in-person at the Grand Hyatt Washington in D.C. (1000 H St NW, Washington, DC 20001). In-person attendance will be limited and granted to early registrants.
During BID, attendees will receive insight into strategic priorities for fiscal year 2024 and beyond. Attendees will hear remarks from BARDA Director, Gary L. Disbrow, BARDA Divisional leaders, and a myriad of BARDA technical experts, industry partners, and special guests. BARDA is thrilled to engage face-to-face with our industry partners and to provide an opportunity for networking with some of the brightest thought leaders in the field of MCM research and development. A full list of speakers will be announced soon!